DSM completes Glycom acquisition

By Jim Cornall contact

- Last updated on GMT

The acquisition was announced in February, 2020.
The acquisition was announced in February, 2020.

Related tags: Dsm, Glycom, HMO

Royal DSM, a global science-based company in nutrition, health and sustainable living, has completed its acquisition of Danish-headquartered Glycom A/S, the world's leading supplier of Human Milk Oligosaccharides (HMO) for an enterprise value of €765m ($836m).

With the acquisition of Glycom, DSM adds HMOs to its portfolio of nutritional lipids, vitamins and nutrient premixes for the early life nutrition industry.

DSM said the high-growth HMO market is set to deliver novel ingredients for next generation early life nutrition solutions.

Glycom is the only fully-integrated HMO provider in the world with its own product development, preclinical and clinical development, regulatory and large-scale production with an innovation roadmap for next-generation HMOs.

As HMOs are believed essential for the development of immunity, cognitive and digestive functions, there is significant interest in HMOs for the dietary supplement market, unmet medical nutrition needs like irritable bowel syndrome, food and beverage applications and for pet foods.

When the announcement was first made in February, Geraldine Matchett and Dimitri de Vreeze co-CEOs of Royal DSM, said, “We are looking forward to welcoming Glycom to DSM. Our companies have a great fit together, with a shared passion for purpose-led and science-based solutions in Nutrition & Health. This acquisition is an attractive and logical next step for DSM enabling us to provide our customers with innovative Early Life Nutrition solutions in our Human Nutrition business.​”

Related topics: Ingredients, Nutritionals, Functional Dairy

Related news

comments

Post your comment

We will not publish your email address on the website

These comments have not been moderated. You are encouraged to participate with comments that are relevant to our news stories. You should not post comments that are abusive, threatening, defamatory, misleading or invasive of privacy. For the full terms and conditions for commenting see clause 7 of our Terms and Conditions ‘Participating in Online Communities’. These terms may be updated from time to time, so please read them before posting a comment. Any comment that violates these terms may be removed in its entirety as we do not edit comments. If you wish to complain about a comment please use the "REPORT ABUSE" button or contact the editors.

Follow us

Featured Events

View more

Products

View more

Webinars